SCM
BEAT

Sio Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Sio Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,200
Closed -$1.31M – 104
2019
Q4 		$1.31M Buy
+28,200
New +$1.22M 0.31% 52

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sio Capital Management's BEAT Position: Q1 2020 in Review

Sio Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 160,015 shares — an estimated $7.41M sold.

Sio Capital Management first reported a position in BEAT in Q4 2015 and held it in 5 quarters. The position peaked at $7.78M in Q3 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

  • Sio Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
  • Sio Capital Management sold 160,015 BioTelemetry, Inc. shares in Q1 2020, an estimated $7.41M.
  • Sio Capital Management first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 5 quarters.
  • Sio Capital Management's BioTelemetry, Inc. position peaked at $7.78M in Q3 2019.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.